We describe the testing of transferability of candidate Reference Methods developed by INSTAND for cholesterol, creatinine, uric acid, and glucose. The methods are based on isotope dilution-gas chromatography-mass spectrometry. The study consisted of two parts: setup of the methods and self-evaluation for readiness in the collaborating laboratory, followed by independent measurements in parallel with INSTAND. Criteria used for judging the transferability and general reliability of the candidate Reference Methods were: the accuracy and precision of the collaborating laboratory and the agreement between the two laboratories. The development and evaluation of candidate Reference Methods (RMs) for the determination of target values for cholesterol, creatunine, uric acid, and glucose in external quality assessment (EQA) and internal accuracy control, according to the Guidelines of the German Medical Society (1) have been previously described (2). The performance requirements of the RMs necessary for these applications have been derived previously from the decision limits for classifying a laboratory as an outlier in the German EQA scheme (3). The methods are all based on isotope dilution-gas chromatography-mass spectrometry (ID-GC/MS). Ordinarily, a study for testing interlaboratory transferabffity of methods is based on the availability of a detailed analytical protocol, including specifications and instructions on equipment, reagents, calibration, measurement, and calculation protocol. But because the laboratory of the University of Ghent (Belgium) had many years of experience with the use of ID-GC/MS as reference methodology for quantifying organic serum components (e.g., 5), the protocol for transfer of the proposed RMs of INSTAND was reduced to a description of sample pretreatment and fundamental GC/MS measurement conditions (type of column, derivative, and mlz values). Reagents but not their origin were specified, except for the primary calibration materials used. In other words, it was left entirely to the responsibility and experience of the collaborating laboratory director to ensure readiness and optimal operation of instrumental equipment and to perform ID-GC/MS measurements under the conditions of a RM. The advantage of this strategy of method transfer was that it became part of an additional "external" evaluation protocol of the rebustness of the proposed RMs against variations of equipment, alternative sources of reagent supply, and differences in ambient operating conditions (4).
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In a trial preceding the transferability study, the laboratory of the University of Ghent performed a self-competence evaluation based on the quantification of SRM 909 serum in addition to four sera previously measured at INSTAND. After this preliminary study, the collaborating laboratory was invited to measure, independently and in parallel with INSTAND, a series of control materials that were completely unknown to both laboratories.
The results of this transferability study are reported here.
Materials and Methods Equipment
Laboratory A used the equipment and instrumentation as described in the accompanying article (2). Laboratory B used a combined GC 
Reagents
The quality and origin of the reagents used by laboratory A are described in the companion article (2). 
Laboratory

Calibration Materials
Laboratories A and B used the same primary calibration materials, i.e., the SRMs from NIST, and internal standards as described previously (2 
Study Design
The transferability study was performed over a 1-year period with commercial control samples that were sent to INSTAND for determination of RM values. On three different occasions, the concentrations of the analytes investigated had to be determined in four to six different sera within a period of 6 weeks. The total number of results per analyte is not always equal (see Table 4 ), because in certain sera, some analytes were not requested by the manufacturers.
Analytical Procedure
The analytical procedure of laboratory B differed from that of laboratory A (see 2) concerning the reconstitution, sampling, and calibration protocols. Laboratory i.e., the Microlab P and Microlab CR700-50 systems. Calibration of each syringe (50 p.L to 5 mL) was performed by weighing 12 times the delivered volume of water at known temperature and atmospheric air pressure on the Mettler B5 balance. Depending on the use of the syringe (at its total or partial volume capacity), calibration was performed for the total volume, or in addition for 50% and 10% of its total volume capacity. The mass of the water was converted to its corresponding volume by using the data for calibration of glassware mentioned in the Handbook of Chemistry and Physics (6). The inaccuracy and imprecision of all pipetting devices used for reconstitution and sampling of serum, calibration, and internal standard solutions did not exceed 0.2%. Attention was paid to the temperature of the solvents at the moment of use of the calibrated syringes. A maximum deviation of 5#{176}C from the temperature at calibration was allowed.
For the ID-GC/MS measurements, laboratory B used the bracketing calibration technique (7). Three different 
Specific procedures.
For each analyte, the protocol for sample pretreatment, derivatization, and GC/MS measurement (m/z values) described by laboratory A was followed. The specific analytical conditions for laboratory B are described in Tables 1 and 2 . The amounts 
Evaluation Protocol
For cholesterol a total of 17 sera were analyzed in both laboratories, for creatinine 18 sera, for glucose 14 sera, and for uric acid 18 sera. For each set of results the individual values, the mean, the standard deviation (SD), and the CV were reported.
To compare the mean results obtained in the two laboratories, we used an advanced linear-regression method instead of the least-squares procedure, because there is analytical error in the variables plotted on both the abscissa and the ordinate. Our method, for which a MS DOS computer program is available on request, is based on maximizing the likelihood function of the composed variables x and y. As a result, estimates for the slope p and the intercept a and the covariance matrix are obtained; from the latter, the SD for $ and a can be derived. From these data, the confidencelimits (P We stress that all results obtained during the transferability study are shown in the following tables and figures (i.e., no outliers have been removed). Table 3 summarizes the results for the quantification of cholesterol, creatinine, uric acid, and glucose in SRM 909 serum by laboratory B during the transferability study. Table 4 tabulates for laboratories A and B the range and mean overall imprecision (expressed as CV) obtained for analysis of each analyte in the different sera. Figure 1 shows the percentage deviation of the results of laboratory B from those of laboratory A vs the respective mean concentrations calculated from the results of both laboratories. Table 5 shows for each analyte the slope, the intercept, and their respective 95% confidenceintervals of the regression equation y = a + lix calculated by the method of advanced linear regression. Table 6 tabulates the values for z at three representative concentrations and calculated for testing the identity of a + fix and x over the whole concentration range. Table 6 also lists the tabulated and calculated t-values at the 95% confidence level and corresponding degrees of freedom.
Discussion
Accuracy
From the data reported for the internal accuracy control with the SRM 909 serum of NIST (Table 3) , it is shown that laboratory B met for all but 1 analyte (glucose) the predefined criteria of INSTAND of a maximum bias of 0.9% (3). Except for glucose, the mean deviations from the certified target value were 0.6%.
For glucose a mean deviation of -1.3% from the expected target concentration was observed. This value exceeds the maximum expected RMs inaccuracy of 0.7% as outlined in reference 2. Therefore, it was suspected 
Imprecision
The data on the intralaboratory CVs (Table 4 ) are in general in accordance with the data reported in Part I (2). They show that the method transfer was achieved without loss of precision for cholesterol and uric acid. A small increase in imprecision was observed for creatinine and glucose in laboratory B, but the imprecision never exceeded the limits of a maximum of 2% as set by Mean+0. for all parameters the outcome of the test after expansion over the whole concentration range (Table 6 ). But again, only for glucose were statistically significant differences between the two laboratories revealed. The same observation was derived from the Student's t-test (P = 0.05) as shown in Table 6 .
For glucose, it is evident that the disagreement be-#{149} Statistically significant (P = 0.05).
tween the two laboratories is in accordance with the negative bias of laboratory B compared with the certified value of the SRM serum of NIST ( deviations, the total error of the RMs should be taken into account. As outlined underAccuracy, the maximum systematic error in laboratories A and B was estimated to be ± 0.7% (except for glucose with an observed mean inaccuracy of 1.3%). This means that in the worst case, i.e., laboratory A deviating from the true value by -0.7% and laboratory B by + 0.7%, the discrepancy between both laboratories due to systematic errors could amount to 1.4%. To this value the statistical uncertainty of the measurement results has to be added. At the 95% confidence level, this uncertainty is calculated according to the t-statistic as: ± t(5) (CV/V'), in the case of a RM value obtained from six determinations (see design of our study). With mean CVs of 0.70%, 1.24%, and 0.89% observed for cholesterol, creatinine, and uric acid (see Table 4 We acknowledge the assistance of Prof. Steyaert for statistical evaluation of the results.
